AVDL
Avadel Pharmaceuticals PLC
NASDAQ: AVDL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$21.64
+0.00% today
Updated 2026-02-12
Market cap
$2.12B
P/E ratio
0.00
P/S ratio
8.55x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$6 – $24
Volume
2.2M
Avadel Pharmaceuticals PLC (AVDL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$21.64
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$73.50
Financial forecast
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.